152 related articles for article (PubMed ID: 8254783)
1. Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion.
Biering-Sørensen F; Høiby N; Nordenbo A; Ravnborg M; Bruun B; Rahm V
J Urol; 1994 Jan; 151(1):105-8. PubMed ID: 8254783
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
Gribble MJ; Puterman ML
Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
[TBL] [Abstract][Full Text] [Related]
3. Re: Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, crossover, placebo controlled study in patients with spinal cord lesion.
Foote JE; Bennett JK; Cowles RS; Green BG; Killorin W
J Urol; 1994 Dec; 152(6 Pt 1):2107-8. PubMed ID: 7966696
[No Abstract] [Full Text] [Related]
4. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction.
Morton SC; Shekelle PG; Adams JL; Bennett C; Dobkin BH; Montgomerie J; Vickrey BG
Arch Phys Med Rehabil; 2002 Jan; 83(1):129-38. PubMed ID: 11782843
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study.
Linsenmeyer TA; Harrison B; Oakley A; Kirshblum S; Stock JA; Millis SR
J Spinal Cord Med; 2004; 27(1):29-34. PubMed ID: 15156934
[TBL] [Abstract][Full Text] [Related]
6. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.
Hull R; Rudy D; Donovan W; Svanborg C; Wieser I; Stewart C; Darouiche R
J Urol; 2000 Mar; 163(3):872-7. PubMed ID: 10687996
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
8. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial.
Darouiche RO; Thornby JI; Cerra-Stewart C; Donovan WH; Hull RA
Clin Infect Dis; 2005 Nov; 41(10):1531-4. PubMed ID: 16231269
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury.
Waites KB; Canupp KC; Brookings ES; DeVivo MJ
J Spinal Cord Med; 1999; 22(3):192-8. PubMed ID: 10685384
[TBL] [Abstract][Full Text] [Related]
11. Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria.
Poirier C; Dinh A; Salomon J; Grall N; Andremont A; Bernard L
Med Mal Infect; 2016 Sep; 46(6):294-9. PubMed ID: 27321478
[TBL] [Abstract][Full Text] [Related]
12. Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.
Wade D; Cooper J; Derry F; Taylor J
Trials; 2019 Apr; 20(1):223. PubMed ID: 30992071
[TBL] [Abstract][Full Text] [Related]
13. [Original strategy for prevention of recurrent symptomatic urinary tract infections in patients with neurogenic bladder: Bacterial interference, state of the art].
Falcou L; Davido B; Even A; Bouchand F; Salomon J; Sotto A; Denys P; Dinh A
Prog Urol; 2018 May; 28(6):307-314. PubMed ID: 29699855
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder.
Hess MJ; Hess PE; Sullivan MR; Nee M; Yalla SV
Spinal Cord; 2008 Sep; 46(9):622-6. PubMed ID: 18392039
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract infection in acute spinal cord injury.
Menon EB; Tan ES
Singapore Med J; 1992 Aug; 33(4):359-61. PubMed ID: 1411664
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial.
Wade DT; Cooper J; Peckham N; Belci M
Clin Rehabil; 2020 Dec; 34(12):1458-1464. PubMed ID: 32762340
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection.
van der Wall E; Verkooyen RP; Mintjes-de Groot J; Oostinga J; van Dijk A; Hustinx WN; Verbrugh HA
Lancet; 1992 Apr; 339(8799):946-51. PubMed ID: 1348797
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis for urodynamic testing in patients with spinal cord injury: a preliminary study.
Darouiche RO; Smith MS; Markowski J
J Hosp Infect; 1994 Sep; 28(1):57-61. PubMed ID: 7806870
[TBL] [Abstract][Full Text] [Related]
19. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction.
Goetz LL; Klausner AP
Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):605-18, viii. PubMed ID: 25064790
[TBL] [Abstract][Full Text] [Related]
20. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study.
Salomon J; Denys P; Merle C; Chartier-Kastler E; Perronne C; Gaillard JL; Bernard L
J Antimicrob Chemother; 2006 Apr; 57(4):784-8. PubMed ID: 16473921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
